Ramipril - NDC Database (Page 5)
186 records found
Start a Discussion
50090-2475 Jun 18, 2008
Ramipril 5 mg Oral Capsule by A-s Medication Solutions
50090-2577 Jun 18, 2008
Ramipril 10 mg Oral Capsule by A-s Medication Solutions
50090-3059 Jun 10, 2008
Ramipril 2.5 mg Oral Capsule by A-s Medication Solutions
50090-3873 Jun 08, 2011
Ramipril 2.5 mg Oral Capsule by A-s Medication Solutions
50090-4597 Jun 10, 2008
Ramipril 5 mg Oral Capsule by A-s Medication Solutions
50090-4691 Jun 10, 2008
Ramipril 10 mg Oral Capsule by A-s Medication Solutions
50090-5673 Jun 08, 2011
Ramipril 5 mg Oral Capsule by A-s Medication Solutions
50090-5730 Jun 08, 2011
Ramipril 10 mg Oral Capsule by A-s Medication Solutions
50090-5947 Jun 08, 2011
Ramipril 2.5 mg Oral Capsule by A-s Medication Solutions
50090-6829 Jun 08, 2011
Ramipril 10 mg Oral Capsule by A-s Medication Solutions
51407-707 Jul 08, 2025
Ramipril 2.5 mg Oral Capsule by Gsms, Incorporated
51407-708 Jul 08, 2025
Ramipril 5 mg Oral Capsule by Gsms, Incorporated
51407-709 Jul 08, 2025
Ramipril 10 mg Oral Capsule by Gsms, Incorporated
51655-144 May 27, 2020
Ramipril 5 mg Oral Capsule by Northwind Pharmaceuticals
51655-296 Nov 16, 2022
Ramipril 5 mg Oral Capsule by Northwind Pharmaceuticals, LLC
51655-301 May 07, 2014
Ramipril 10 mg/301 Oral Capsule by Northwind Pharmaceuticals
51655-346 May 27, 2020
Ramipril 10 mg Oral Capsule by Northwind Pharmaceuticals
51655-347 May 28, 2020
Ramipril 2.5 mg Oral Capsule by Northwind Pharmaceuticals
51655-406 Sep 06, 2022
Ramipril 10 mg Oral Capsule by Northwind Pharmaceuticals, LLC
51655-904 Apr 27, 2023
Ramipril 10 mg Oral Capsule by Northwind Pharmaceuticals, LLC
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us .
